Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.FGEN · Entity 7431 | SVP, CHINA OPERATIONS | March 06, 2025 | March 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date March 06, 2025 · Filed March 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 294,903 |
Ending reported balance
After 2025-03-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-06 · Tax withholding · Disposed 7,008 · Balance 294,544 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Row 2 · 2025-03-06 · Grant · Acquired 781 · Balance 295,325 F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025. Row 3 · 2025-03-06 · Tax withholding · Disposed 422 · Balance 294,903 F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025.
F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,225 | $36.55 | $117,873.75 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,028 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $36.01 to $36.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $19.39 | $109,068.75 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · derivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,209 Underlying: Common Stock · 5,625 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $39.87 | $224,268.75 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,628 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $39.51 to $40.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $19.39 | $109,068.75 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,120 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · derivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,834 Underlying: Common Stock · 2,120 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,400 | $40.75 | $138,550.00 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,628 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $40.58 to $41.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,225 | $40.00 | $89,000.00 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,028 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $39.58 to $40.56. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 2,120 | $19.39 | $41,106.80 |
DisclosureSEC source: 0001209191-19-050490 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 11, 2019 00:26 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 8,437 | $41.68 | $351,654.16 |
DisclosureSEC source: 0001209191-19-049097 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,133 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · derivative · entry 9 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,954 Underlying: Common Stock · 5,625 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 584 | $43.68 | $25,509.12 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $43.61 to $43.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,816 | $42.94 | $77,979.04 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,154 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $42.61 to $43.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,225 | $42.05 | $135,611.25 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,970 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $41.61 to $42.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $19.39 | $109,068.75 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · derivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,579 Underlying: Common Stock · 5,625 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 300 | $44.67 | $13,401.00 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $44.62 to $44.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,325 | $43.79 | $233,181.75 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,870 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $43.47 to $44.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $19.39 | $109,068.75 |
DisclosureSEC source: 0001209191-19-047446 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 796 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · derivative · entry 10 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,204 Underlying: Common Stock · 796 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,829 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · derivative · entry 9 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,130 Underlying: Common Stock · 4,829 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 100 | $45.72 | $4,572.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,525 | $45.13 | $249,343.25 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,670 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $44.71 to $45.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 796 | $19.39 | $15,434.44 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 4,829 | $29.66 | $143,228.14 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · derivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,959 Underlying: Common Stock · 5,625 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 600 | $45.14 | $27,084.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $45.09 to $45.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,025 | $44.75 | $224,868.75 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,170 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $44.09 to $45.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $29.66 | $166,837.50 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · derivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,584 Underlying: Common Stock · 5,625 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $44.02 | $247,612.50 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $43.60 to $44.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $29.66 | $166,837.50 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,120 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · derivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,209 Underlying: Common Stock · 2,120 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $44.08 | $247,950.00 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $43.81 to $44.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 2,120 | $29.66 | $62,879.20 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,480 | $38.31 | $133,318.80 |
DisclosureSEC source: 0001209191-19-035675 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,075 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 08, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · derivative · entry 9 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,329 Underlying: Common Stock · 5,625 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| May 08, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,500 | $46.62 | $69,930.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,937 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $46.54 to $46.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 4,125 | $46.20 | $190,575.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,437 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $45.54 to $46.53. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $29.66 | $166,837.50 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · derivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,954 Underlying: Common Stock · 5,625 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| May 07, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 200 | $47.44 | $9,488.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,937 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $47.32 to $47.56. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,500 | $46.70 | $163,450.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,137 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $46.32 to $47.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,925 | $46.04 | $88,627.00 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,637 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $45.325 to $46.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2019 Filed May 10, 2019 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $29.66 | $166,837.50 |
DisclosureSEC source: 0001209191-19-028666 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.